Christophe Bernard.

Christophe Bernard

Director of research
Institute of Systems Neuroscience

Christophe Bernard is director of research at the Institute of Systems Neuroscience, INSERM U1106. His main interest is to understand brain dynamics in health and disease, with a focus on epilepsy.

He acts as a reviewing editor for Science Advances, and formerly for Science and the Journal of Neuroscience. He created and is the editor-in-chief of eNeuro, the online open-access journal of the Society for Neuroscience. eNeuro is designed to serve and educate the neuroscience community, promoting reproducibility, publishing negative results and sensitizing scientists to open science and better data interpretation with a focus on statistics and experimental bias.

Bernard obtained his Ph.D. in neuroscience from Pierre and Marie Curie University, did his postdoctoral research at the University of Southampton and spent a sabbatical at Baylor College of Medicine. He participated in the development of organic technologies to record and control brain activity, which earned him the Felix Innovation Prize, and in the development of the Virtual Mouse Brain.

Explore more from The Transmitter

Nerve fibers from the human graft in mouse brain.

Human brain organoids flourish in emptied mouse cortex

The chimeric mice could help untangle the biology of human brain development or conditions such as autism.

By Brianna Abbott
16 September 2026 | 6 min read

What if Hegel were a neuroscientist?

Andrea Gambarotto shares what Hegel and enactivism have in common: an agency-first approach to understanding minds and brains.

By Paul Middlebrooks
16 September 2026 | 1 min read
Illustration of genetic associations.

This paper changed my life: Transformative work in addiction neuroscience

A 2011 Nature study found that loss of a nicotinic receptor subunit leads to increased nicotine intake in mice. The work set the standard for how to functionally validate genetic association study findings in neuroscience.

By Jibran Khokhar
16 September 2026 | 6 min read